Medeloop Reels In $15.5 Million

<p><strong>MENLO PARK<&sol;strong> &&num;8212&semi; <u>Medeloop<&sol;u>&comma; a medical research platform&comma; has closed a &dollar;15&period;5 million Series A funding round&period; Led by venture capital firm <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;ddLLVt4CC5vHSLvYxWbC&lowbar;jx17U-uxkn9hhP2gYQIU5Jmt9seBzDPT2YLS33yfDyelrlM1v5KKP-00a&lowbar;fqWbMjQ&equals;&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>Inovia Capital<&sol;u><&sol;a> and supported by contributions from <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;dICz02Ics4A56jDXb-Q8xTaalgSaFysRYr88xAxxRBqLVRbz2HxHH1jA8r3TGSVOsn4BDy3yLNXsxpeL6KaRUA&equals;&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>Icon Ventures<&sol;u><&sol;a>&comma; this investment underscores the strong confidence in Medeloop&&num;8217&semi;s mission to revolutionize medical research&period; The round also welcomed participation from previous investors <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;a183fS2GCHfYDBgUcG9cslEl-7taSzX8zDW3jiMmPcZISYybi1hpsw7ZL3z904nDyoP0WX-d0IkSZzEwPaCFafU76qEPd2wZAQhHixEiT&lowbar;M&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>General Catalyst<&sol;u><&sol;a> and <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;BwSTwL0n32iiDr6QG0-EEgAIhH1g&lowbar;2auG2qj&lowbar;HlNZ7pYatKN7-MmqHPNyOZoOnVKqTZERBwCvI2U6DVU1yZ86X9cFweCFBd8z8yVYCDcmQ4&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>Maven Ventures<&sol;u><&sol;a>&comma; as well as new investors including <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;BBzc5uI04s0CAxrkZAFGkhFfYxkams0VCLlmDmWI54G8mOeKgWi7MjOqM9tGU84gH2dwuovNkkdH2TuYWJYclPWbi&lowbar;AT4IIkb3kv-HzT1Uo&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>Healthier Capital<&sol;u><&sol;a>&comma; <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;SffbtNgA9fm4WPoOmqKUEirvIgucH-zwIsg0FcphTe0vcIzGCN2QdmUPlEQUlBjfVi88&lowbar;pfBUVyU0eL6V1gGU9&lowbar;lgbykiAbC4H6f4CcV5a5DHEpMIwJbhAPIf4Y74Vd6Cxd8QnFV3tVWajyBBSIsCA&equals;&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>Up2 Opportunity Fund<&sol;u><&sol;a>&comma; and <a title&equals;"" href&equals;"https&colon;&sol;&sol;www&period;globenewswire&period;com&sol;Tracker&quest;data&equals;3wEuCxK4YgYvqX1JQgjpo-zsqGzaojUB0C883vpd3HoUqQAtncgaHf5bGtH9&lowbar;&lowbar;xPfRuQ3LWJguXiSb3GOda8Nw&equals;&equals;" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener"><u>CFO Advisors<&sol;u><&sol;a> each bringing valuable industry expertise to support Medeloop’s growth&period;<&sol;p>&NewLine;<p>Medeloop&&num;8217&semi;s platform dramatically accelerates the pace of research by streamlining processes and employing autonomous AI agents to handle tasks traditionally requiring large teams&period; This innovation not only speeds up research but also democratizes it&comma; empowering individual researchers and smaller institutions to compete with well-funded&comma; large-scale operations&period; By transforming data into a graph database and enriching it with connections to external datasets&comma; the analytics platform can perform analyses up to 1&comma;000 times faster than traditional methods&comma; paving the way for novel insights and transformative breakthroughs in medical research&period;<&sol;p>&NewLine;<p>&&num;8220&semi;I founded Medeloop driven by the personal mission of finding a cure for my daughter’s Complex Regional Pain Syndrome &lpar;CRPS&rpar;—a condition still eluding effective treatment&comma;&&num;8221&semi; explains Rene Caissie&comma; CEO&period; &&num;8220&semi;This experience revealed the inefficiencies in current medical research and the critical need for innovative solutions&period; Supported by leading investors like Inovia Capital and Icon Ventures&comma; we&&num;8217&semi;ve crafted a platform that accelerates research&comma; reduces costs&comma; and enables significant advancements in patient outcomes&period; Our goal is to revolutionize healthcare research&comma; delivering profound impacts where they are desperately needed&period;&&num;8221&semi;<&sol;p>&NewLine;<p>Building on this financial capital&comma; Medeloop is set to expand its end-to-end AI-powered platform&comma; which significantly simplifies the complexities of medical research&period; The comprehensive suite includes a grant platform for identifying and applying for funding&comma; a dual-component studies platform featuring a mobile app for participants and a web app for researchers&comma; a no-code analytics platform for rapid data analysis&comma; and a manuscript publication platform&period; These tools are seamlessly integrated&comma; designed to allow researchers to efficiently manage every aspect of a study from inception to publication&period;<&sol;p>&NewLine;<p>&&num;8220&semi;We couldn’t be more excited to lead Medeloop’s Series A&comma; supporting Rene and his incredible team as they reinvent the tech stack for medical research&comma;&&num;8221&semi; says Inovia Partner Magaly Charbonneau&period; &&num;8220&semi;As we delved into the business&comma; we spoke to dozens of researchers across North America and were impressed by their enthusiasm for the platform&comma; which speaks to the profound impact Medeloop will have on their workflow&comma; future innovations&comma; and ultimately&comma; patient outcomes&period; We can’t wait to get Medeloop into their hands&excl;&&num;8221&semi;<&sol;p>&NewLine;